# Inpatient Clinical Trial of NAC

> **NCT03581084** · PHASE4 · TERMINATED · sponsor: **University of California, San Francisco** · enrollment: 1 (actual)

## Conditions studied

- Asthma

## Interventions

- **DRUG:** N-acetylcysteine

## Key facts

- **NCT ID:** NCT03581084
- **Lead sponsor:** University of California, San Francisco
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2018-07-06
- **Primary completion:** 2018-07-13
- **Final completion:** 2018-10-06
- **Target enrollment:** 1 (ACTUAL)
- **Why stopped:** The study was redesigned to be conducted in an outpatient setting.
- **Last updated:** 2021-10-26

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03581084

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03581084, "Inpatient Clinical Trial of NAC". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03581084. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*